1xf0: Difference between revisions

New page: left|200px<br /> <applet load="1xf0" size="450" color="white" frame="true" align="right" spinBox="true" caption="1xf0, resolution 2.00Å" /> '''Crystal structure o...
 
No edit summary
Line 1: Line 1:
[[Image:1xf0.gif|left|200px]]<br />
[[Image:1xf0.gif|left|200px]]<br /><applet load="1xf0" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1xf0" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1xf0, resolution 2.00&Aring;" />
caption="1xf0, resolution 2.00&Aring;" />
'''Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) complexed with delta4-androstene-3,17-dione and NADP'''<br />
'''Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) complexed with delta4-androstene-3,17-dione and NADP'''<br />


==Overview==
==Overview==
Human type 5 17beta-hydroxysteroid dehydrogenase (17beta-HSD5;AKR1C3), plays a major role in the metabolism of androgens in peripheral tissues., In prostate basal cells, this enzyme is involved in the transformation of, dehydroepiandrosterone into dihydrotestosterone, the most potent androgen., It is thus a potential target for prostate cancer therapy because it is, understood that the testosterone formation by this enzyme is an important, factor, particularly in patients who have undergone surgical or medical, castration. Here we report the first structure of a human type 5, 17beta-HSD in two ternary complexes, in which we found that the, androstenedione molecule has a different binding position from that of, testosterone. The two testosterone-binding orientations in the, substrate-binding site demonstrate the structural basis of the alternative, binding and multispecificity of the enzyme. Phe306 and Trp227 are the key, residues involved in ligand recognition as well as product release. A, safety belt in the cofactor-binding site enhances nicotinamide adenine, dinucleotide phosphate binding and accounts for its high affinity as, demonstrated by kinetic studies. These structures have provided a dynamic, view of the enzyme reaction converting androstenedione to testosterone as, well as valuable information for the development of potent enzyme, inhibitors.
Human type 5 17beta-hydroxysteroid dehydrogenase (17beta-HSD5;AKR1C3) plays a major role in the metabolism of androgens in peripheral tissues. In prostate basal cells, this enzyme is involved in the transformation of dehydroepiandrosterone into dihydrotestosterone, the most potent androgen. It is thus a potential target for prostate cancer therapy because it is understood that the testosterone formation by this enzyme is an important factor, particularly in patients who have undergone surgical or medical castration. Here we report the first structure of a human type 5 17beta-HSD in two ternary complexes, in which we found that the androstenedione molecule has a different binding position from that of testosterone. The two testosterone-binding orientations in the substrate-binding site demonstrate the structural basis of the alternative binding and multispecificity of the enzyme. Phe306 and Trp227 are the key residues involved in ligand recognition as well as product release. A safety belt in the cofactor-binding site enhances nicotinamide adenine dinucleotide phosphate binding and accounts for its high affinity as demonstrated by kinetic studies. These structures have provided a dynamic view of the enzyme reaction converting androstenedione to testosterone as well as valuable information for the development of potent enzyme inhibitors.


==About this Structure==
==About this Structure==
1XF0 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ACT, NAP and ASD as [http://en.wikipedia.org/wiki/ligands ligands]. The following page contains interesting information on the relation of 1XF0 with [[http://pdb.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb92_1.html Anabolic Steroids]]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1XF0 OCA].  
1XF0 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ACT:'>ACT</scene>, <scene name='pdbligand=NAP:'>NAP</scene> and <scene name='pdbligand=ASD:'>ASD</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. The following page contains interesting information on the relation of 1XF0 with [[http://pdb.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb92_1.html Anabolic Steroids]]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1XF0 OCA].  


==Reference==
==Reference==
Line 16: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Labrie, F.]]
[[Category: Labrie, F.]]
[[Category: Lin, S.X.]]
[[Category: Lin, S X.]]
[[Category: Qiu, W.]]
[[Category: Qiu, W.]]
[[Category: Zhou, M.]]
[[Category: Zhou, M.]]
Line 25: Line 24:
[[Category: beta-hairpin]]
[[Category: beta-hairpin]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:04:31 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:54:08 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA